Cannabix Technologies Inc. BLO

Company Overview

Cannabix Technologies Inc. is a Canadian technology company focused on the development of cannabis and alcohol breath-testing devices for law enforcement, workplace safety, and related public safety applications. The company operates primarily within the drug detection, breath analytics, and safety technology industries, with its core emphasis on creating non-invasive breath-based screening systems intended to detect recent tetrahydrocannabinol (THC) consumption. Public disclosures indicate that the company’s primary commercial objective is the advancement and eventual commercialization of portable marijuana breathalyzer technology.

The company’s principal business activities center on research and development of breath collection hardware, mass spectrometry-related detection systems, and complementary screening technologies. Cannabix has also pursued development work involving alcohol breath screening and contactless screening concepts. Its strategic positioning is tied to the potential regulatory and operational demand for rapid roadside and workplace cannabis impairment testing following cannabis legalization trends in Canada and certain international markets. Cannabix evolved from an early-stage technology venture into a specialized developer of breath diagnostics and detection technologies through internal development efforts, patent activity, and collaboration with scientific and engineering partners.

Business Operations

Cannabix generates activity primarily through technology development and intellectual property advancement rather than large-scale commercial product sales. The company’s operations have historically focused on the advancement of its Cannabix Marijuana Breathalyzer platform and related detection systems intended for law enforcement agencies, employers, and industrial safety environments. Public filings indicate that operations include prototype development, engineering design, software integration, laboratory testing, and validation activities associated with breath sampling and THC detection technologies.

The company’s business activities are centered in Canada, though its technology ambitions target broader international enforcement and workplace safety markets. Cannabix has disclosed work involving proprietary breath capture systems, sensor integration, and analytical technologies designed to identify THC in exhaled breath. The company also maintains intellectual property assets through patent filings and technology licensing arrangements where applicable. Available public information indicates that Cannabix has worked with external laboratories, engineering consultants, and scientific collaborators to support development and validation efforts, although commercially scaled partnerships and recurring revenue-generating deployments remain limited based on publicly available disclosures.

Strategic Position & Investments

Cannabix’s strategic direction has focused on positioning itself within the emerging cannabis impairment detection market, particularly as governments and employers seek practical alternatives to blood or urine testing for recent cannabis use. The company has emphasized continued investment in prototype refinement, scientific validation, and regulatory-oriented testing designed to support future commercialization opportunities. Public disclosures also indicate ongoing efforts to improve device portability, detection sensitivity, and real-time usability for roadside and workplace environments.

The company has pursued intellectual property development through patents and technology enhancements tied to breath analysis systems. Cannabix has also explored adjacent technologies involving alcohol screening and contactless breath analysis applications. While the company remains primarily in the development stage, its strategic value proposition is tied to potential adoption within transportation safety, industrial workforce compliance, and law enforcement screening sectors. Data regarding large-scale acquisitions, material operating subsidiaries, or transformative portfolio investments is limited in publicly available filings, and some commercialization timelines remain subject to regulatory and technical validation outcomes.

Geographic Footprint

Cannabix Technologies Inc. is headquartered in Canada and is publicly traded on the Canadian Securities Exchange under the ticker symbol BLO. The company’s operational and research activities have primarily been associated with Canadian development facilities and research partnerships, while its target markets extend to broader international jurisdictions where cannabis legalization and impairment enforcement policies are evolving.

The company’s intended market reach includes potential opportunities across North America, particularly Canada and the United States, where workplace safety and impaired-driving enforcement remain active regulatory concerns. Public disclosures also reference broader international commercialization interest, although evidence of significant operational infrastructure outside Canada remains limited based on currently available public information.

Leadership & Governance

Cannabix Technologies Inc. is overseen by a management team and board focused on advancing breath-testing technologies and positioning the company within the cannabis detection and public safety technology sectors. Corporate strategy has generally emphasized technology validation, intellectual property expansion, and eventual commercialization opportunities tied to evolving cannabis regulation and enforcement needs.

Key executives and leadership figures identified in public company disclosures include:

• Rav Mlait – Chief Executive Officer
• Kal Malhi – Director
• Richard Russell – Chief Financial Officer
• Riaz Bandali – Director
• Dr. Raj Attariwala – Scientific Advisor

Public filings and corporate materials indicate that leadership has prioritized scientific development partnerships, prototype advancement, and regulatory-oriented testing initiatives as core components of the company’s long-term strategy. Some executive and advisory roles may change over time, and investors typically reference current Canadian Securities Exchange filings and corporate disclosures for the most up-to-date governance information.